about
Aerosol Delivery of siRNA to the Lungs. Part 1: Rationale for Gene Delivery SystemsPermeation of Therapeutic Drugs in Different Formulations across the Airway Epithelium In VitroStudy of nebulization delivery of aerosolized fluorescent microspheres to the avian respiratory tract.Comparison of intrapulmonary and systemic pharmacokinetics of colistin methanesulfonate (CMS) and colistin after aerosol delivery and intravenous administration of CMS in critically ill patients.Animals devoid of pulmonary system as infection models in the study of lung bacterial pathogensNanoparticle surface charge impacts distribution, uptake and lymph node trafficking by pulmonary antigen-presenting cells.Bridging the Gap Between Science and Clinical Efficacy: Physiology, Imaging, and Modeling of Aerosols in the Lung.Ultrasonic nebulization platforms for pulmonary drug delivery.In vitro and in vivo testing methods for respiratory drug delivery.Benchmarking of Human Dose Prediction for Inhaled Medicines from Preclinical In Vivo Data.Characterization of Calu-3 cell monolayers as a model of bronchial epithelial transport: organic cation interaction studies.Toxicity of orally inhaled drug formulations at the alveolar barrier: parameters for initial biological screening.Modification of disodium cromoglycate passage across lung epithelium in vitro via incorporation into polymeric microparticles.Pulmonary Pharmacokinetics of Colistin Following Administration of Dry Powder Aerosols in Rats.Development of a Multicompartment Permeability-Limited Lung PBPK Model and Its Application in Predicting Pulmonary Pharmacokinetics of Antituberculosis Drugs.The in vitro and in vivo investigation of inhaled migraine therapies using a novel aerosol delivery system consisting of an air pressurized capsule device (APCD) in combination with a pMDI spacer for endotracheal dosing into beagle dogs.Respirable controlled release polymeric colloid (RCRPC) of bosentan for the management of pulmonary hypertension: in vitro aerosolization, histological examination and in vivo pulmonary absorption.The in vitro and in vivo investigation of a novel small chamber dry powder inhalation delivery system for preclinical dosing to rats.Development and evaluation of Chitosan nanoparticles based dry powder inhalation formulations of Prothionamide.PvdQ Quorum Quenching Acylase Attenuates Pseudomonas aeruginosa Virulence in a Mouse Model of Pulmonary Infection.Carriers for the targeted delivery of aerosolized macromolecules for pulmonary pathologiesEvaluating the Controlled Release Properties of Inhaled Nanoparticles Using Isolated, Perfused, and Ventilated Lung ModelsMultilayered Cultures of NSCLC cells grown at the Air-Liquid Interface allow the efficacy testing of inhaled anti-cancer drugs
P2860
Q28392004-912D40D5-4CF7-4AF7-AD78-5E210214EFE3Q28547301-16D0CDEE-498B-45FE-AC43-A344328BAB33Q34362474-16EAB678-97B9-4AB1-AF97-ED86CE6B96BEQ34597749-B0042764-B4BD-4CEE-BCB0-3954115F7C5BQ35048029-242F273C-6F91-478B-872C-CB2C9B061C65Q36821628-5446E9B3-4672-469E-867F-B7DD278C206DQ36827889-D172E80F-A1F4-4F40-B148-5836AFD36AA8Q37748786-DB40CBC5-9D74-4384-B598-602064BB46A5Q37822755-72BE83B4-67FB-414E-9FB7-6CAE537DE63EQ38690068-9A92B7A1-CCA0-4E80-851C-C464B0A755BAQ39262937-D0B25395-FFD3-429C-A908-A266AD486848Q39346006-516CB927-2F81-4FB9-BAE0-EA37110ACD8EQ39421517-D5FA414D-18ED-4362-B520-46EB65DB058BQ40093588-6A44B8FD-6346-4570-9E43-8FE5D6356D55Q40358160-3DA55919-06E2-4BAB-95D6-F3FC33C7B320Q40926461-A7EC82B4-1CB0-4BD2-BBAA-8928A856342DQ46647863-93AB14DA-5296-4447-B1DD-26285F432414Q47641145-04D00341-82C3-4D08-A427-F4BC19E1971AQ48165979-18C91F0B-3873-4727-897D-2F35C01DEE6BQ54213053-F6D3EC00-6E43-49D7-86D2-96F165A1BBFCQ57172145-6B74D0A4-CFDD-4EAA-A8A1-976DF88828B8Q58691546-2654F397-225E-4FB9-BDCA-FE9D5E9A2A7EQ58701299-13371EFC-B644-49E1-972A-2289A9A97971
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Preclinical models for pulmonary drug delivery.
@en
Preclinical models for pulmonary drug delivery.
@nl
type
label
Preclinical models for pulmonary drug delivery.
@en
Preclinical models for pulmonary drug delivery.
@nl
prefLabel
Preclinical models for pulmonary drug delivery.
@en
Preclinical models for pulmonary drug delivery.
@nl
P2860
P1476
Preclinical models for pulmonary drug delivery.
@en
P2093
Cláudia A Fernandes
Rita Vanbever
P2860
P304
P356
10.1517/17425240903241788
P407
P577
2009-11-01T00:00:00Z